Skip to main content
English
中文
Log In
Email address
Password
Log in
Log in with ORCID
New user? Click here to register.
Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
People
Organizations
Statistics
English
中文
Log In
Email address
Password
Log in
Log in with ORCID
New user? Click here to register.
Have you forgotten your password?
Home
Chung Shan Medical University
Project/研究計畫(老師)
Nonaisoprenol 經由調控 RIPK1 降低全面性細胞死亡 (PANoptosis) 並改善急性腎損傷 (AKI) 之相關分子機轉
Export
Statistics
Options
Show all metadata (technical view)
Nonaisoprenol 經由調控 RIPK1 降低全面性細胞死亡 (PANoptosis) 並改善急性腎損傷 (AKI) 之相關分子機轉
Details
Primary Data
Project title
113學年度國家科學及技術委員會補助研究計畫
Acronym
專題研究計畫
Principal Investigator
吳勝文
Start Date
August 1, 2024
Organizations
College of Medicine
School of Medicine
Partner Organizations
National Science and Technology Council
Description
Description
計畫名稱:Nonaisoprenol 經由調控 RIPK1 降低全面性細胞死亡 (PANoptosis) 並改善急性腎損傷 (AKI) 之相關分子機轉
成果報告:未達繳交期限
執行起迄:2024/08/01~2027/07/31
總核定金額:4,050,000元 (各年度經費明細)
計畫概述:本計畫主要目標為在動物與細胞模式,深入探討Nonaisoprenol對於調控RIPK1而改善急性腎損傷中凋亡、焦亡及壞死性凋亡,與所構成的全面性細胞死亡 (PANoptosis) 的潛在藥理效...(詳)
Show more